Prediction of adenomyosis diagnosis based on MRI - 09/06/23

Doi : 10.1016/j.jeud.2023.100028 
C.O. Rees a, b, c, , M. van de Wiel a, J. Nederend d, A. Huppelschoten a, M. Mischi b, H.A.A.M. van Vliet a, c, B.C. Schoot a, b, c
a Department of Obstetrics and Gynaecology, Catharina Hospital, Eindhoven, Netherlands 
b Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, Netherlands 
c Department of Reproductive Medicine, Ghent University Hospital, Ghent, Belgium 
d Department of Radiology, Catharina Hospital, Eindhoven, Netherlands 

Corresponding author. Afdeling Gynaecologie & Verloskunde, Michelangelolaan 2, 5623EJ Eindhoven, Netherlands.Afdeling Gynaecologie & VerloskundeMichelangelolaan 2Eindhoven5623EJNetherlands

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Highlights

We present the first clinical diagnostic tool combining both MRI and clinical parameters to predict histopathology adenomyosis diagnosis on an individual level with good accuracy.
Our model would be especially useful in cases of mild or atypical adenomyosis where MRI is indicated.
External validation is needed in other (prospective) settings, where clinicians can apply our results to aid in patient counselling.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Objective

Development of a multivariate prediction model based on MRI and clinical parameters for histological adenomyosis diagnosis.

Materials and methods

This single centre retrospective cohort study took place in the gynaecological department of a referral hospital. In all, 296 women undergoing hysterectomy with preoperative pelvic MRI between 2007–2022 were included. MRI scans were retrospectively assessed for adenomyosis markers (junctional zone [JZ] parameters, high signal intensity [HSI] foci in a blinded fashion. A multivariate regression model for histopathological adenomyosis diagnosis was developed based on MRI and clinical variables from univariate analysis with p<0.1 and factors deemed clinically relevant.

Results

131/296 women (44.3%) had histopathological adenomyosis. Patients had comparable age at hysterectomy, BMI and clinical symptoms, p>0.05. Adenomyosis patients more often had: undergone a curettage (22.1% vs. 8.9%, p=0.002), a higher mean JZ thickness (9.40 vs. 8.35mm, p<.001), maximal JZ thickness (16.00 vs. 13.40mm, p<.001), mean JZ/myometrium ratio (0.56 vs. 0.49, p=.040), and JZ differential (8.60 vs. 8.15mm, p=.003). Presence of HSI foci was the strongest predictor for adenomyosis (39.7% vs. 8.9%, p<.001). Based on the parameters age and BMI, history of curettage, dysmenorrhoea, abnormal uterine bleeding (AUB), mean JZ, JZ differential5mm, JZ/myometrium ratio>40, and presence of HSI foci, a predictive model was created with a good area under the curve (AUC) of .776.

Conclusions

This is the first study to create a diagnostic tool based on MRI and clinical parameters for adenomyosis diagnosis. After sufficient external validation, this model could function as a useful clinical decision-making tool in women with suspected adenomyosis.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Adenomyosis, MRI, Hysterectomy, Pathology, Diagnosis

Abbreviations : MRI, TVUS, JZ, BMI, OR, AUB


Mappa


© 2023  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 2

Articolo 100028- Giugno 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • A patient-oriented workshop on sexual pain and endometriosis: Preliminary evidence for improvements in painful intercourse self-efficacy
  • Natasha L. Orr, Jessica L. Sutherland, Alice Huang, Kate J. Wahl, Heather Noga, Lori A. Brotto, Ciana Maher, Mohamed A. Bedaiwy, Christina Williams, Catherine Allaire, Paul J. Yong
| Articolo seguente Articolo seguente
  • Enhanced expression of certain biomarkers as a predictive factor for malignant transformation of atypic lesions in ovarian endometriosis
  • S.A. Levakov, N.A. Sheshukova, T.A. Gromova, M.G. Kaviladze

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.